Nuveen Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $2.13M | Hold |
354,842
| – | – | ﹤0.01% | 2361 |
|
2024
Q3 | $1.82M | Hold |
354,842
| – | – | ﹤0.01% | 2459 |
|
2024
Q2 | $1.28M | Sell |
354,842
-198,919
| -36% | -$720K | ﹤0.01% | 2603 |
|
2024
Q1 | $1.78M | Sell |
553,761
-79,456
| -13% | -$255K | ﹤0.01% | 2454 |
|
2023
Q4 | $3.1M | Buy |
633,217
+4,019
| +0.6% | +$19.7K | ﹤0.01% | 2207 |
|
2023
Q3 | $3.43M | Sell |
629,198
-117,385
| -16% | -$640K | ﹤0.01% | 2055 |
|
2023
Q2 | $5.01M | Sell |
746,583
-479,557
| -39% | -$3.22M | ﹤0.01% | 1906 |
|
2023
Q1 | $10.8M | Buy |
1,226,140
+419,347
| +52% | +$3.7M | ﹤0.01% | 1428 |
|
2022
Q4 | $6.16M | Buy |
806,793
+359,342
| +80% | +$2.75M | ﹤0.01% | 1798 |
|
2022
Q3 | $3.19M | Buy |
447,451
+12,861
| +3% | +$91.6K | ﹤0.01% | 2149 |
|
2022
Q2 | $3.52M | Buy |
434,590
+109,768
| +34% | +$888K | ﹤0.01% | 2152 |
|
2022
Q1 | $4.11M | Buy |
324,822
+22,124
| +7% | +$280K | ﹤0.01% | 2159 |
|
2021
Q4 | $8.49M | Sell |
302,698
-42,034
| -12% | -$1.18M | ﹤0.01% | 1797 |
|
2021
Q3 | $11.7M | Sell |
344,732
-53,523
| -13% | -$1.82M | ﹤0.01% | 1669 |
|
2021
Q2 | $16.3M | Buy |
398,255
+21,161
| +6% | +$865K | ﹤0.01% | 1530 |
|
2021
Q1 | $15.2M | Sell |
377,094
-62,164
| -14% | -$2.5M | ﹤0.01% | 1521 |
|
2020
Q4 | $26M | Buy |
439,258
+162,942
| +59% | +$9.64M | 0.01% | 1077 |
|
2020
Q3 | $13.4M | Buy |
276,316
+24,558
| +10% | +$1.19M | 0.01% | 1319 |
|
2020
Q2 | $12.2M | Buy |
251,758
+15,637
| +7% | +$757K | 0.01% | 1351 |
|
2020
Q1 | $6.56M | Buy |
236,121
+181,567
| +333% | +$5.04M | ﹤0.01% | 1553 |
|
2019
Q4 | $1.63M | Sell |
54,554
-1,534
| -3% | -$45.9K | ﹤0.01% | 2504 |
|
2019
Q3 | $1.73M | Buy |
56,088
+42,718
| +320% | +$1.32M | ﹤0.01% | 2464 |
|
2019
Q2 | $646K | Buy |
+13,370
| New | +$646K | ﹤0.01% | 2910 |
|